# Heat Biologics Inc. (HTBX)

Source: https://www.quantisnow.com/company/HTBX
Generated: 2026-11-11T08:12:22.505Z

- Ticker: HTBX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- Website: heatbio.com

## About

Heat Biologics, Inc., a biopharmaceutical company, engages in the development of immunotherapies to activate patient's immune system against cancer through T-cell activation and expansion. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and ComPACT, which delivers antigen driven T-cell activation and specific co-stimulation in a single product. The company develops HS-110, which is in phase II clinical trials to treat patients with advanced non-small cell lung cancer; and HS-130 that is in phase I clinical trial for the treatment of advanced solid tumors. Its preclinical stage products include PTX-35, a humanized affinity matured monoclonal antibody, which is a functional agonist of human TNFRSF25; TNFRSF25 modulators for various immunotherapy approaches; and COVID-19 vaccine. Heat Biologics, Inc. has collaboration with Waisman Biomanufacturing to manufacture COVID-19 Vaccine. The company was incorporated in 2008 and is headquartered in Morrisville, North Carolina.

## Latest HTBX news and filings

- 2023-01-05 22:14 UTC [SEC Form 8-K] [Heat Biologics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits](https://www.quantisnow.com/insight/heat-biologics-inc-filed-sec-form-8-k-entry-into-a-3880287)
- 2022-12-30 21:06 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Heat Biologics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-heat-biologics-inc-amendment-3858946)
- 2022-12-09 22:07 UTC [SEC Form 8-K] [Heat Biologics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/heat-biologics-inc-filed-sec-form-8-k-leadership-update-financial-3790633)
- 2022-12-09 22:03 UTC [SEC Form 4] [SEC Form 4 filed by Wolf Jeffrey Alan](https://www.quantisnow.com/insight/sec-form-4-filed-by-wolf-jeffrey-alan-3790589)
- 2022-12-09 22:01 UTC [SEC Form 4] [SEC Form 4 filed by Smith Edward B Iii](https://www.quantisnow.com/insight/sec-form-4-filed-by-smith-edward-b-iii-3790579)
- 2022-12-09 22:00 UTC [SEC Form 4] [SEC Form 4 filed by Prendergast John K A](https://www.quantisnow.com/insight/sec-form-4-filed-by-prendergast-john-k-a-3790547)
- 2022-12-09 21:59 UTC [SEC Form 4] [SEC Form 4 filed by Ostrander William L.](https://www.quantisnow.com/insight/sec-form-4-filed-by-ostrander-william-l-3790532)
- 2022-12-09 21:58 UTC [SEC Form 4] [SEC Form 4 filed by Monahan John J](https://www.quantisnow.com/insight/sec-form-4-filed-by-monahan-john-j-3790523)
- 2022-11-14 21:27 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Heat Biologics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-heat-biologics-inc-3682908)
- 2022-11-14 21:23 UTC [SEC Form 8-K] [Heat Biologics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/heat-biologics-inc-filed-sec-form-8-k-results-of-operations-3682686)
- 2022-10-03 21:26 UTC [SEC Form S-8] [SEC Form S-8 filed by Heat Biologics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-heat-biologics-inc-3486848)
- 2022-09-16 20:34 UTC [SEC Form 8-K] [Heat Biologics Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/heat-biologics-inc-filed-sec-form-8-k-leadership-update-submission-3422577)
- 2022-08-22 11:30 UTC [SEC Form 8-K] [Heat Biologics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/heat-biologics-inc-filed-sec-form-8-k-other-events-financial-3314489)
- 2022-08-10 20:10 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Heat Biologics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-heat-biologics-inc-3266200)
- 2022-08-10 20:06 UTC [SEC Form 8-K] [Heat Biologics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/heat-biologics-inc-filed-sec-form-8-k-results-of-operations-3266071)
- 2022-07-28 20:21 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Heat Biologics Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-heat-biologics-inc-3202841)
- 2022-06-06 20:29 UTC [SEC Form 8-K] [Heat Biologics Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits (Amendment)](https://www.quantisnow.com/insight/heat-biologics-inc-filed-sec-form-8-k-completion-of-acquisition-2994219)
- 2022-05-16 20:58 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Heat Biologics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-heat-biologics-inc-2897316)
- 2022-05-16 20:44 UTC [SEC Form 8-K] [Heat Biologics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/heat-biologics-inc-filed-sec-form-8-k-results-of-operations-2897079)
- 2022-05-10 12:00 UTC [Conference Announcement] [NightHawk Biosciences to Present at the 4th Annual Treg Directed Therapies Summit on PTX-35](https://www.quantisnow.com/insight/nighthawk-biosciences-to-present-at-the-4th-annual-treg-directed-2857143)
- 2022-05-03 11:15 UTC [SEC Form 8-K] [Heat Biologics Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/heat-biologics-inc-filed-sec-form-8-k-amendments-to-articles-2815066)
- 2022-05-03 11:00 UTC [Heat Biologics Completes Name Change to NightHawk Biosciences; Trading to Commence Under "NHWK" Effective at the Market Open Today](https://www.quantisnow.com/insight/heat-biologics-completes-name-change-to-nighthawk-biosciences-trading-to-2814831)
- 2022-04-27 12:09 UTC [Market Chatter] [Heat Biologics (nighthawk Biosciences) Announces That Its Elusys Therapeutics Subsidiary Has Executed A Contract To Deliver ANTHIM To The Canadian Government For C$7.9M](https://www.quantisnow.com/insight/heat-biologics-nighthawk-biosciences-announces-that-its-elusys-therapeutics-subsidiary-2776216)
- 2022-04-27 12:00 UTC [Heat Biologics (NightHawk Biosciences) Announces that its Elusys Therapeutics Subsidiary has Executed a Contract to Deliver ANTHIM® to the Canadian Government](https://www.quantisnow.com/insight/heat-biologics-nighthawk-biosciences-announces-that-its-elusys-therapeutics-subsidiary-2775919)
- 2022-04-25 12:00 UTC [SEC Form 8-K] [Heat Biologics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/heat-biologics-inc-filed-sec-form-8-k-other-events-financial-2760241)
- 2022-04-20 12:06 UTC [SEC Form 8-K] [Heat Biologics Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/heat-biologics-inc-filed-sec-form-8-k-completion-of-acquisition-2740861)
- 2022-04-20 12:00 UTC [Mergers & Acquisitions] [Heat Biologics ("NightHawk Biosciences") Completes Acquisition of Elusys Therapeutics](https://www.quantisnow.com/insight/heat-biologics-nighthawk-biosciences-completes-acquisition-of-elusys-therapeutics-2740650)
- 2022-04-19 15:01 UTC [Market Chatter] [Heat Biologics Announces Planned Name Change To NightHawk Biosciences; Will Trade Under Ticker 'NHWK' Effective May 3, 2022](https://www.quantisnow.com/insight/heat-biologics-announces-planned-name-change-to-nighthawk-biosciences-will-2736094)
- 2022-04-19 15:00 UTC [Mergers & Acquisitions] [Heat Biologics Announces Planned Name Change to NightHawk Biosciences, Reflecting Company's Evolution, Therapeutic Pipeline Expansion, Vertical Integration and New Biodefense Capabilities](https://www.quantisnow.com/insight/heat-biologics-announces-planned-name-change-to-nighthawk-biosciences-reflecting-2736022)
- 2022-04-18 20:00 UTC [REMINDER: Heat Biologics to Host Planned Investor and Media Livestream Event on Tuesday, April 19th at 10:30 AM ET to Discuss Latest Developments](https://www.quantisnow.com/insight/reminder-heat-biologics-to-host-planned-investor-and-media-livestream-2731375)
- 2022-04-18 14:29 UTC [Market Insight] [Heat Biologics' Subsidiary Outlines Development of New Commercial/Biodefense Biomanufacturing Facility](https://www.quantisnow.com/insight/heat-biologics-subsidiary-outlines-development-of-new-commercialbiodefense-biomanufacturing-facility-2730000)
- 2022-04-18 12:35 UTC [SEC Form 8-K] [Heat Biologics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/heat-biologics-inc-filed-sec-form-8-k-other-events-financial-2729188)
- 2022-04-14 16:37 UTC [Market Chatter] [Heat Biologics' Announces Planned Investor And Media Livestream Event To Discuss Latest Developments For April 19](https://www.quantisnow.com/insight/heat-biologics-announces-planned-investor-and-media-livestream-event-to-2722440)
- 2022-04-14 16:35 UTC [Heat Biologics' Announces Planned Investor and Media Livestream Event to Discuss Latest Developments](https://www.quantisnow.com/insight/heat-biologics-announces-planned-investor-and-media-livestream-event-to-2722432)
- 2022-04-11 19:57 UTC [Market Chatter] [Heat Biologics Shares Spike To Session High, Up 8%; Co. Purchased Elusys Therapeutics In Dec. 2021, Elusys's ANTHIM Was Approved For Treatment Of Inhalation Of Anthrax In US, Canada, Europe, UK](https://www.quantisnow.com/insight/heat-biologics-shares-spike-to-session-high-up-8-co-2705513)
- 2022-03-30 15:18 UTC [Market Chatter] [Watching HIV Drug Manufacturers After Reports Department Of Justice Investigating Reports Of Counterfeit Drugs](https://www.quantisnow.com/insight/watching-hiv-drug-manufacturers-after-reports-department-of-justice-investigating-2647587)
- 2022-03-25 12:00 UTC [Heat Biologics Unveils Enhanced Allogeneic Cell Manufacturing Process](https://www.quantisnow.com/insight/heat-biologics-unveils-enhanced-allogeneic-cell-manufacturing-process-2624870)
- 2022-03-24 13:09 UTC [Market Chatter] [Heat Biologics 8-K Shows Co., Elusys Therapeutics Waived (Until Apr. 30, 2022) Their Rights To Terminate Deal, Plan Of Merger, Reorganization](https://www.quantisnow.com/insight/heat-biologics-8-k-shows-co-elusys-therapeutics-waived-until-apr-2619741)
- 2022-03-24 13:00 UTC [SEC Form 8-K] [Heat Biologics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/heat-biologics-inc-filed-sec-form-8-k-other-events-financial-2619642)
- 2022-03-23 12:30 UTC [Leadership Update] [Heat Biologics Announces Appointment of Greg Burel, Former Director of the Strategic National Stockpile, to its Biothreat Advisory Board and as Senior Advisor to the Company](https://www.quantisnow.com/insight/heat-biologics-announces-appointment-of-greg-burel-former-director-of-2612905)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/HTBX
- Earnings history: https://www.quantisnow.com/earnings/HTBX
- Dividend history: https://www.quantisnow.com/dividends/HTBX
- Insider transactions: https://www.quantisnow.com/insiders/HTBX
- Options chain: https://www.quantisnow.com/options/HTBX
- SEC 8-K filings only: https://www.quantisnow.com/company/HTBX/8-k
- RSS and alerts for HTBX: https://www.quantisnow.com/docs/rss-feeds.md